Wednesday February 10 2010 |
Biotechnology feed
|
All feeds
Home
Marketing Services
Antibodies
Careers
Directories
Drugs
Events
Genes
InDepth
News
Reports
Videos
A-Z
Business
Health
Drugs
Sources
Americas
Europe
Asia
Cancer
Cardio-
Diabetes
Bird Flu
Swine Flu
Summaries
Post News
Search
Headache News and Headlines
Headache News updated every 30 minutes from thousands of internet sites.
Sign-up to BioPortfolio's
Headache
news alerts
.
Site Map
>
Biotechnology News
>
Health News
> Headache
.
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
Pharma Live:
similar ...
Trigemina Initiates Phase IIa Clinical Trial in Chronic Daily Headache
Therapeutics Daily:
similar ...
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
Yahoo! Canada:
similar ...
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
Genetic Engineering News:
similar ...
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
Freshnews.com:
similar ...
Trigemina Conducting Phase IIa Clinical Trial in Chronic Daily Headache
Therapeutics Daily:
similar ...
Mirror, Mirror by the Chair
Consultant Live:
similar ...
TI commences Phase IIa clinical trial for its lead molecule in CDH
News-Medical.Net:
similar ...
Diabetes Q&A: What Clues Help Distinguish Type 1 From Type 2 Diabetes?
Consultant Live:
similar ...
Kidney Damage in Earthquake Crush Victims may be Prevented by Headache Pill
MedIndia:
similar ...
Focusing on Depression in Expectant and New Fathers
Consultant Live:
similar ...
Acanthosis Nigricans
Consultant Live:
similar ...
Aradigm's first U.S. sale of SUMAVEL DosePro needle-free delivery system triggers $4M milestone payment
News-Medical.Net:
similar ...
Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL DosePro
Pharma Live:
similar ...
Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL DosePro
Therapeutics Daily:
similar ...
Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*
Genetic Engineering News:
similar ...
Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*
Yahoo! Canada:
similar ...
Aradigm Receives $4 Million Milestone Payment Upon First Commercial Sale of SUMAVEL* DosePro*
SmartBrief:
similar ...
Headache in cerebral venous thrombosis: incidence, pattern and location in 200 consecutive patients
MDLinx:
similar ...
Pearls: Headache
MDLinx:
similar ...
